SECISBP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.70440328517429E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.17379999995138E-06 |
Normal-vs-Stage2 |
1.244300E-02 |
Normal-vs-Stage3 |
1.33226762955019E-15 |
Normal-vs-Stage4 |
1.62592161956354E-12 |
Stage1-vs-Stage2 |
9.451800E-01 |
Stage1-vs-Stage3 |
3.84460000502074E-08 |
Stage1-vs-Stage4 |
1.40140000048916E-07 |
Stage2-vs-Stage3 |
5.164600E-03 |
Stage2-vs-Stage4 |
2.795900E-03 |
Stage3-vs-Stage4 |
6.547600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.23372448210557E-12 |
Normal-vs-AfricanAmerican |
3.717600E-03 |
Normal-vs-Asian |
2.590200E-01 |
Caucasian-vs-AfricanAmerican |
3.998400E-02 |
Caucasian-vs-Asian |
2.275400E-01 |
AfricanAmerican-vs-Asian |
7.023000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.71740399679265E-12 |
Normal-vs-Female |
2.05059999999202E-05 |
Male-vs-Female |
3.004500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.80699999999356E-06 |
Normal-vs-Age(41-60Yrs) |
5.10119999574954E-08 |
Normal-vs-Age(61-80Yrs) |
2.16715534406831E-12 |
Normal-vs-Age(81-100Yrs) |
4.718400E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.020800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.426000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.488800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.793500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.659800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.476800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.959800E-01 |
Normal-vs-Grade 2 |
5.9743000000001E-05 |
Normal-vs-Grade 3 |
1.7027490528676E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
1.835980E-02 |
Grade 1-vs-Grade 3 |
4.73130000000488E-06 |
Grade 1-vs-Grade 4 |
3.35359995329298E-09 |
Grade 2-vs-Grade 3 |
7.19450000019606E-07 |
Grade 2-vs-Grade 4 |
1.74316117096396E-12 |
Grade 3-vs-Grade 4 |
9.7190999999941E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.117300E-03 |
Normal-vs-ccB subtype |
1.11022302462516E-15 |
ccA subtype-vs-ccB subtype |
2.30490071473355E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.32230021271585E-10 |
Normal-vs-N1 |
2.1505996983251E-10 |
N0-vs-N1 |
1.787410E-04 |
|
|